Trial intelligence / Profile preview

Aminophylline for prevention of post-dural puncture headache after cesarean section under combined spinal-epidural anesthesia

ChiCTR1800016831Phase 4Recruiting

Sponsor
Nanjing Medical University Affiliated Nanjing Hospital
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of aminophylline in post-dural puncture headache (PDPH) (2 arms), sponsored by Nanjing Medical University Affiliated Nanjing Hospital. Primary endpoint: Post-dural puncture headache. Started Jun 2018; status: recruiting.

02

Drugs

aminophylline
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on ChiCTR1800016831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call